COVERAGE

February 5, 2020 – Interview with Scenic’s founder Thijn Brummelkamp in Labiotech

Through quirks of genetics, some people are naturally resilient to heritable diseases. Thijn Brummelkamp, Managing Director and founder of the Dutch startup Scenic Biotech, explains how the company is using this genetic resilience to treat rare diseases and cancer. [Read more]